Get the latest information on the groundbreaking research and prestigious awards presented at AAIC.
Check back for press releases from AAIC 2021 once the conference begins on Monday, July 26.
Get b-roll video, soundbites, photos, fact sheets and position statements for AAIC 2021.
Check back for news highlights about AAIC 2021 once the conference begins on Monday, July 26.
The Alzheimer’s Association International Conference (AAIC) is the largest and most influential international meeting dedicated to advancing dementia science. AAIC 2021 will be held in a hybrid format — both in-person in Denver, USA and online. News media interested in covering the conference and receiving embargoed news materials should submit a request for press credentials.
On This Page:
Complimentary registration as a journalist for AAIC is solely for those individuals who will produce news coverage of the conference. News media outlets must be in existence and regularly (daily/weekly) covering health-related topics, including brain science/research, for at least six months to be eligible to receive embargoed news materials. Learn more about news media qualifications at AAIC.
News media must apply for press credentials and be approved in order to receive advance access to embargoed news materials. Approvals for news media/reporters are at the discretion of the Alzheimer’s Association.
Please refer to the Guidelines for News Media for more information on the AAIC news embargo policy.
All materials presented at the Alzheimer's Association International Conference 2021 (AAIC) are embargoed for publication and broadcast until the date and time of presentation at the conference, or an embargo date and time specified by the Alzheimer's Association in advance. Please contact the Alzheimer’s Association Public Relations Department at AAICmedia@alz.org with any questions.
All news media representatives, scientists, funders of science presented at AAIC, and AAIC exhibitors/sponsors agree to be bound by the AAIC news embargoes laid out in this policy, in addition to release times stated on news releases and other news materials issued by the Alzheimer’s Association and AAIC.
Embargoed AAIC news materials are intended specifically for each journalist's individual use and are not to be shared in any way with anyone until the news embargo date/time has passed. By accepting embargoed AAIC news materials, journalists acknowledge that the materials are solely for their use and that they will not distribute, publish, broadcast or in any other way share them before the news embargo time has passed.
If a reporter or news media outlet breaks an AAIC news embargo, the Alzheimer's Association reserves the right to revoke their press access and credentials for the current event and future Alzheimer's Association conferences and events.
AAIC abstracts, sessions and schedules will be available to registered journalists through a password protected website and the AAIC app. Data and details for abstracts included in the AAIC news program will not be on the website or app until the news embargo has passed.
Alzheimer's Association® Public Relations Department
Maria C. Carrillo, Ph.D.
Chief Science Officer, Alzheimer's Association
Rebecca M. Edelmayer, Ph.D.
Director of Scientific Engagement, Alzheimer's Association
Carl V. Hill, Ph.D., MPH
Chief Diversity, Equity & Inclusion Officer, Alzheimer’s Association
Claire Sexton, DPhil
Director of Scientific Programs & Outreach, Alzheimer’s Association
Heather M. Snyder, Ph.D.
Vice President of Medical & Scientific Relations, Alzheimer's Association
Christopher Weber, Ph.D.
Director of Global Science Initiatives, Alzheimer’s Association